For the quarter ending 2025-12-31, CTOR has $109,973,406 in assets. $51,559,705 in debts.
| Balance Sheets | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|
| Cash and cash equivalents | 7,295,451 | 3,924,908 | 112 | |
| Accounts receivable, net of allowances | 4,049,111 | - | - | |
| Inventory | 22,639,342 | 22,286,693 | 17,208,967 | |
| Prepaid expenses | 3,162,940 | 1,331,280 | 1,100,000 | |
| Total current assets | 37,146,844 | 27,542,881 | 18,309,079 | |
| In-process research and development, net of accumulated amortization | 72,826,562 | 73,400,000 | 73,400,000 | |
| Total other assets | 72,826,562 | 73,400,000 | 73,400,000 | |
| Total assets | 109,973,406 | 100,942,881 | 91,709,079 | |
| Accounts payable | 10,446,900 | 13,234,684 | 8,667,419 | |
| License payable | 18,250,000 | 22,650,000 | 28,400,000 | |
| Accrued expenses | 4,518,916 | 4,093,124 | 8,458,554 | |
| Due to related party-Related Party | 11,494,578 | 9,513,771 | 7,464,362 | |
| Total current liabilities | 44,710,394 | 49,491,579 | 52,990,335 | |
| Deferred tax liability | 3,049,200 | 2,784,960 | 2,520,720 | |
| Note payable to related party-Related Party | 3,800,111 | 3,800,111 | 3,800,111 | |
| Total liabilities | 51,559,705 | 56,076,650 | 59,311,166 | |
| Common stock - 0.0001 par value 400,000,000 shares authorized at december 31, 2025 and september 30, 2025 84,797,846 and 83,513,442 shares issued and outstanding at december 31, 2025 and september 30, 2025, respectively | 8,480 | 8,351 | 7,155 | |
| Additional paid-in capital | 127,979,246 | 108,897,836 | 91,434,058 | |
| Accumulated deficit | -69,574,025 | -64,039,956 | -59,043,300 | |
| Total stockholders equity | 58,413,701 | 44,866,231 | 32,397,913 | |
| Total liabilities and stockholders equity | 109,973,406 | 100,942,881 | 91,709,079 | |
CITIUS ONCOLOGY, INC. (CTOR)
CITIUS ONCOLOGY, INC. (CTOR)